Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic Interval
- PMID: 28111027
- DOI: 10.1053/j.ajkd.2016.10.024
Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic Interval
Abstract
Background: Hyperkalemia is common among hemodialysis patients and is associated with morbidity and mortality. The long interdialytic interval is likewise associated with adverse outcomes. However, the interplay among serum potassium, dialysis cycle phase, and clinical outcomes has not been examined.
Study design: Retrospective observational study.
Setting & participants: 52,734 patients receiving in-center hemodialysis at a large dialysis organization during 2010 and 2011 contributed 533,889 potassium measurements (230,634 on Monday; 285,522 on Wednesday; 17,733 on Friday).
Predictor: Serum potassium concentration, day of the week of potassium measurement.
Outcomes: Death, hospitalization, emergency department (ED) visit.
Results: There was a significant association between higher serum potassium and risk of hospitalization within 96 hours that was of greater magnitude on Fridays (389 hospitalizations) than Mondays or Wednesdays (4,582 and 4,629 hospitalizations, respectively; P for interaction = 0.008). Serum potassium of 5.5 to <6.0 (vs the referent category of 4.0-<4.5 mEq/L) was associated with increased risk of hospitalization on Fridays, with an adjusted OR of 1.68 (95% CI, 1.22-2.30). However, serum potassium of 5.5 to <6.0 mEq/L was associated with only mild elevation of risk on Mondays and no significantly increased risk on Wednesdays (adjusted ORs of 1.12 [95% CI, 1.00-1.24] and 1.04 [95% CI, 0.94-1.16], respectively). Associations of elevated serum potassium (6.0-<6.5 mEq/L or greater) with death and ED visit were significant, but did not differ based on day of the week.
Limitations: There were insufficient observations to detect effect modification by day of the week for deaths, ED visits, and specific causes of hospitalizations. Confounding may have influenced results.
Conclusions: Higher serum potassium is associated with increased short-term risk of hospitalization, ED visit, and death. The association between serum potassium and hospitalization risk is modified by day of the week, consistent with a contribution of accumulated potassium to adverse outcomes following the long interdialytic interval. Further work is needed to determine whether directed interventions ameliorate this risk.
Keywords: Hyperkalemia; emergency department visit; end-stage renal disease (ESRD); hemodialysis; hospitalization; long interdialytic interval; mortality; phase of dialytic cycle; potassium gradient; serum potassium.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.
Comment in
-
Serum Potassium and the Long Interdialytic Interval: Minding the Gap.Am J Kidney Dis. 2017 Jul;70(1):4-7. doi: 10.1053/j.ajkd.2017.04.007. Am J Kidney Dis. 2017. PMID: 28646982 No abstract available.
Similar articles
-
Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients.Nephrol Dial Transplant. 2018 Jul 1;33(7):1207-1214. doi: 10.1093/ndt/gfx241. Nephrol Dial Transplant. 2018. PMID: 28992343 Free PMC article.
-
Serum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study.Am J Nephrol. 2016;44(3):179-86. doi: 10.1159/000448341. Epub 2016 Sep 3. Am J Nephrol. 2016. PMID: 27592170
-
Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).Am J Kidney Dis. 2017 Feb;69(2):266-277. doi: 10.1053/j.ajkd.2016.09.015. Epub 2016 Nov 17. Am J Kidney Dis. 2017. PMID: 27866964 Free PMC article.
-
Dialysis Prescription and Sudden Death.Semin Nephrol. 2018 Nov;38(6):570-581. doi: 10.1016/j.semnephrol.2018.08.003. Semin Nephrol. 2018. PMID: 30413252 Free PMC article. Review.
-
Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals?Am J Nephrol. 2015;41(4-5):400-8. doi: 10.1159/000435842. Epub 2015 Jun 27. Am J Nephrol. 2015. PMID: 26139107 Review.
Cited by
-
Effects of a Mobile-App-Based Self-Management Support Program For Elderly Hemodialysis Patients.Healthc Inform Res. 2020 Apr;26(2):93-103. doi: 10.4258/hir.2020.26.2.93. Epub 2020 Apr 30. Healthc Inform Res. 2020. PMID: 32547806 Free PMC article.
-
Association of dyskalemias with short-term health care utilization in patients with advanced CKD.J Manag Care Spec Pharm. 2021 Oct;27(10):1403-1415. doi: 10.18553/jmcp.2021.27.10.1403. J Manag Care Spec Pharm. 2021. PMID: 34595956 Free PMC article.
-
DEVELOPMENT OF A PORTABLE BLOOD POTASSIUM MONITORING DEVICE FOR DIALYSIS PATIENTS.Proc Des Med Devices Conf. 2020 Apr;2020:V001T05A004. doi: 10.1115/dmd2020-9066. Epub 2020 Jul 27. Proc Des Med Devices Conf. 2020. PMID: 35253014 Free PMC article.
-
Recommendations for the management of hyperkalemia in patients receiving renin-angiotensin-aldosterone system inhibitors.Intern Emerg Med. 2024 Mar;19(2):295-306. doi: 10.1007/s11739-023-03427-0. Epub 2023 Sep 29. Intern Emerg Med. 2024. PMID: 37775712 Free PMC article. Review.
-
The association between longer haemodialysis treatment times and hospitalization and mortality after the two-day break in individuals receiving three times a week haemodialysis.Nephrol Dial Transplant. 2019 Sep 1;34(9):1577-1584. doi: 10.1093/ndt/gfz007. Nephrol Dial Transplant. 2019. PMID: 30820580 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical